A new study on BPC-157 was published on August 1, 2026. The publication, titled "Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel," appeared in the journal 3 Biotech. BPC-157 remains classified as an unapproved research compound. The publication describes the development of a chitosan based hydrogel formulation incorporating BPC-157, along with characterization of its biocompatibility. No efficacy outcomes or clinical results are included in the information provided about this publication. This entry reflects only the existence and bibliographic details of the study as recorded. Readers interested in the compound generally can consult the compound overview for additional context.</body_markdown>
<parameter name="sources">["https://pubmed.ncbi.nlm.nih.gov/42555375/"]